SGLT2相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants

DPP-4抑制剂、GLP-1受体激动剂和SGLT2抑制剂的药物特异性、组织病理学分层血液系统恶性肿瘤风险：一项纳入270,471名参与者的网络荟萃分析

期刊:Journal of Hematology & Oncology

影响因子:40.4

doi:10.1186/s13045-026-01788-5

Lin, Pao-Yen; Zeng, Bing-Syuan; Chen, Jiann-Jy; Zeng, Bing-Yan; Suen, Mein-Woei; Hung, Chao-Ming; Hsu, Chih-Wei; Stubbs, Brendon; Chen, Yen-Wen; Chen, Tien-Yu; Lei, Wei-Te; Hsu, Shih-Pin; Shiue, Yow-Ling; Su, Kuan-Pin; Li, Cheng-Ta; Wang, Hung-Yu; Tseng, Ping-Tao; Liang, Chih-Sung

发表日期：2026

文献求助收藏

SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes

SGLT2抑制剂与GLP-1受体激动剂对2型糖尿病患者肾脏结局的影响

期刊:Jama Internal Medicine

影响因子:23.3

doi:10.1001/jamainternmed.2025.7409

Jensen, Simon K; Heide-Jørgensen, Uffe; Andersen, Ina T; Bonnesen, Kasper; Fu, Edouard L; Thomsen, Reimar W; Christiansen, Christian F

发表日期：2026

文献求助收藏

Effectiveness of Pre-Transplant Dual GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapy on All-Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target-Trial Emulation

移植前双重GLP-1受体激动剂和SGLT2抑制剂治疗对肥胖合并2型糖尿病器官移植候选者全因死亡率的影响：一项Target试验模拟研究

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202518813

Huang, Yu-Nan; Tsou, Min-Yu; Li, Pin-Hung; Chen, Jo-Ching; Liu, Yen-Liang; Meyerowitz-Katz, Gideon; Tsai, Tsung-Hsun; Su, Pen-Hua

发表日期：2026

文献求助收藏

Beneficial effects of SGLT1/2 and SGLT2 inhibitors on vaso-occlusive events and organ damage in sickle cell disease mice

SGLT1/2 和 SGLT2 抑制剂对镰状细胞病小鼠血管阻塞事件和器官损伤的有益作用

期刊:Cardiovascular Research

影响因子:13.3

doi:10.1093/cvr/cvag003

Jin, Bo-Ram; Kumari, Tripti; Lee, Jingu; Kim, Jae-Sung; Bokorova, Radka; Gheware, Atish; Ripoll, Carla Valenzuela; Sargazi, Alireza; Jeong, Soi; Hyun, Young-Min; Saif Ur Rehman, Sana; Razani, Babak; Lee, Janet S; Javaheri, Ali; Cho, Jaehyung

细胞生物学

发表日期：2026

文献求助收藏

Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study

一项针对英国主要族裔群体中2型糖尿病患者SGLT2和DPP4抑制剂治疗选择算法的验证：一项回顾性队列研究

期刊:Lancet Regional Health-Europe

影响因子:13

doi:10.1016/j.lanepe.2025.101547

Güdemann, Laura M; Young, Katherine G; Cardoso, Pedro; Mateen, Bilal A; Holman, Rury R; Sattar, Naveed; Pearson, Ewan R; Hattersley, Andrew T; Jones, Angus G; Shields, Beverley M; Dennis, John M

发表日期：2026

文献求助收藏

Inpatient safety, effectiveness of SGLT2 inhibitors and GLP-1 RAs in type 2 diabetes: ENDOCARE, a pragmatic prospective cohort study

住院患者使用SGLT2抑制剂和GLP-1受体激动剂治疗2型糖尿病的安全性和有效性：ENDOCARE，一项实用性前瞻性队列研究

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-026-03156-6

Moreno-Pérez, Óscar; Tejera-Muñoz, Antonio; Leiva-Mora, Nuria; Santacruz, Elisa; Sánchez-Ortiga, Ruth; Arrarte, Vicente; Climent-Grana, Eduardo; Sandin, Miriam; Riera, Gerónima; Lopez-Mondejar, Pedro; López-Muñoz, Beatriz; Navarro, Clara; Guillen-Morote, Cristina; Roldán-Sánchez, Ada; Sánchez-Pacheco, Myriam; Abad-González, Ángel Luis; Llorens, Pere; Pico-Alfonso, Antonio; Serrano-Gotarredona, Joaquín

发表日期：2026

文献求助收藏

Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling

SGLT2抑制剂治疗后红细胞增多症与房颤患者抗凝治疗结局：基于反事实模型的真实世界分析

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-026-03117-z

Qi, Zuo; Liu, Jie; Gu, Tianshu; Wu, Ning; Liu, Junyu; Zhao, Jinhua; Tse, Gary; Lip, Gregory Y H; Chen, Kang-Yin; Liu, Tong

细胞生物学

发表日期：2026

文献求助收藏

SGLT2 inhibitors reduce the salt sensitivity of blood pressure in type 2 diabetes via enhanced postprandial natriuresis

SGLT2抑制剂通过增强餐后钠排泄来降低2型糖尿病患者血压的盐敏感性

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-026-03095-2

Chiriacò, Martina; Tricò, Domenico; Sacchetta, Luca; Nesti, Lorenzo; Cimbalo, Noemi; Santoni, Lorenza; Gallo, Simone; Baldi, Simona; Scozzaro, Tiziana; Giannoni, Alberto; Natali, Andrea

发表日期：2026

文献求助收藏

Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection

2型糖尿病精准医疗：靶向SGLT2抑制剂治疗以保护肾脏

期刊:Diabetologia

影响因子:10.2

doi:10.1007/s00125-025-06577-2

Jansz, Thijs T; Young, Katherine G; Hopkins, Rhian; McGovern, Andrew P; Shields, Beverley M; Hattersley, Andrew T; Jones, Angus G; Pearson, Ewan R; Bingham, Coralie; Oram, Richard A; Dennis, John M

发表日期：2026

文献求助收藏

Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies

SGLT2抑制剂与GLP-1受体激动剂联合治疗2型糖尿病患者的有效性和安全性：队列研究的系统评价和荟萃分析

期刊:Diabetologia

影响因子:10.2

doi:10.1007/s00125-025-06565-6

Colombijn, Julia M T; de Leijer, Jan F; Visseren, Frank L J; Verhaar, Marianne C; van Raalte, Daniël H; Sattar, Naveed; Vernooij, Robin W M; van Sloten, Thomas T

发表日期：2026

文献求助收藏